The Foundation is supporting a clinical trial of music therapy in combination with standard treatment for 15 patients with early-stage Huntington’s disease. This genetic neurodegenerative disease is characterised by movement disorders combined with psychiatric impairment in 35-75% of cases. This pilot study aims to evaluate whether music therapy reduces irritability, impulsivity and anxiety, and improves the quality of life of patients diagnosed with this illness in the early stages and their carers.
For this study, the MUSIC CARE © tool will be used, an innovative software program that brings patients into a state of relaxation using the “U sequence” method, which involves reducing the musical rhythm, orchestral formation, frequency and volume (descending U-shaped phase). :
The study will be undertaken at the Clinical Investigation Centre, CIC INSERM 1402 at Poitiers University Hospital, under the scientific responsibility of Dr Isabelle Benatru, hospital practitioner in neurology and head of the Parkinson’s Expert Centre and the Huntington’s Disease Competency Centre at Poitiers university hospital.

